Boston Private Equity partner economics sit above pure commercial corporate for the same book size, but the decisive variables are not the Am Law average. The 2026 Am Law 100 rankings, covering 2025 financial performance, put average profits per equity partner at $3.59 million—up 14.0% year over year—while revenue per lawyer hit $1.39 million. David Lat's 2026 readout also noted nonequity partner ranks grew nearly 7% against roughly 2% equity growth, a leverage shift that funds multi-year PE guarantees without expanding equity seats equally.
Sartori's Boston PE compensation read is blunt. Among 48 PE-originator respondents over 24 months inside the same cohort of 250 structured interviews, partners price three variables harder than headline PEP: year-1 guarantee cash versus the step-down schedule, client-credit rules on shared fund originations, and capital-call timing. Among 16 PE partner-level offer discussions Sartori tracked in Boston over 36 months, 56% of declinations cited guarantee step-down or credit language rather than base draw alone. Mid-market equity PE laterals more often negotiate packages keyed to portable originations in the $3–6 million band; income partners accept only with a written equity-path memo.
Associate lockstep still sets the junior cost base PE partners manage: Biglaw Investor's 2026 scale puts first-year base at $235,000 and eighth-year base at $455,000, raising break-even on every underwritten franchise seat. For lateral Private Equity partner recruitment, we treat PEP as market context and concentrate friction work on guarantee design, capital contribution and fund-clear portability. Healthcare PE books add portfolio-company biotech walls that pure software or industrial buyout books rarely carry at the same density.